Picture of Laboratorios Farmaceuticos Rovi logo

ROVI — Laboratorios Farmaceuticos Rovi News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Spanish stocks - Factors to watch on Feb 7

Feb 7 (Reuters) - The following Spanish stocks may be
affected by newspaper reports and other factors on Friday.
Reuters has not verified the newspaper reports, and cannot vouch
for their accuracy:
    
    SABADELL  SABE.MC  
    Sabadell  SABE.MC  on Friday said its fourth-quarter net
profit rose 75% year-on-year thanks partly to its British unit
TSB while cheering investors up with a 1 billion euro ($1.04
billion) share buyback as it tries to fend off a takeover from
BBVA  BBVA.MC .  urn:newsml:reuters.com:*:nL8N3OY0A5
    
    TALGO  TLGO.MC  
    A Basque consortium comprising shareholders of steelmaker
Sidenor, together with the regional government and local bank
Kutxabank, on Thursday made an offer for a 29.8% stake in
Spanish train maker Talgo  TLGO.MC .  urn:newsml:reuters.com:*:nL1N3OX0O6
    Separately, according to sources familiar with the matter,
Poland's state investment fund PFR and India's Jupiter Wagons
 JUWL.NS  are preparing bids for 100% of Talgo, Spanish online
news website El Confidencial reported on Friday, citing
unidentified sources with knowledge of the matter.
    
    ROVI  ROVI.MC  
    Rovi said on Friday it expects its earnings before interest,
taxes, depreciation and amortization in 2024 were lower than
market consensus.  urn:newsml:reuters.com:*:nFWN3OX1WX

    For today's European market outlook double click on  .EU . 
    For real-time moves on the Spanish blue-chip index IBEX
please double click on  .IBEX  
    For IBEX constituent stocks highlight .IBEX in the command
box and press the F3 button on your keyboard 
    For latest news on Spanish stock moves double click  HOT-ES 
    For Spanish language market report double click on  .MES 
    For latest Eurostocks report please double click on  .EU 
($1 = 0.9636 euros)

 (Gdansk Newsroom; Gdansk.newsroom@thomsonreuters.com
+48 58 769 66 00)

Recent news on Laboratorios Farmaceuticos Rovi

See all news